MedPath

Zinc

Generic Name
Zinc
Brand Names
Vitafol-one, Wilzin
Drug Type
Small Molecule
Chemical Formula
Zn
CAS Number
7440-66-6
Unique Ingredient Identifier
J41CSQ7QDS

Overview

A metallic element of atomic number 30 and atomic weight 65.38. It is a necessary trace element in the diet, forming an essential part of many enzymes, and playing an important role in protein synthesis and in cell division. Zinc deficiency is associated with anemia, short stature, hypogonadism, impaired wound healing, and geophagia. It is identified by the symbol Zn . A newer study suggests implies that an imbalance of zinc is associated with the neuronal damage associated with traumatic brain injury, stroke, and seizures . Understanding the mechanisms that control brain zinc homeostasis is, therefore, imperative to the development of preventive and treatment regimens for these and other neurological disorders . In addition to the above, recent review articles have already demonstrated the important role of zinc in the pathophysiology and treatment of affective disorders, plus discussed the potential value of zinc as a marker of these diseases . Most recently, research has shown that polymorphism of the common polymorphism in zinc transporter SLC30A8/ZnT8 may increase susceptibility to type 2 diabetes provided novel insights into the role of zinc in diabetes .

Indication

Zinc can be used for the treatment and prevention of zinc deficiency/its consequences, including stunted growth and acute diarrhea in children, and slowed wound healing. It is also utilized for boosting the immune system, treating the common cold and recurrent ear infections, as well as preventing lower respiratory tract infections .

Associated Conditions

  • Candidiasis
  • Common Cold
  • Diaper Dermatitis
  • Diaper Rash
  • Eye redness
  • Iron Deficiency (ID)
  • Ocular Irritation
  • Skin Irritation
  • Sunburn
  • Wilson's Disease
  • Zinc Deficiency

Research Report

Published: Aug 5, 2025

Zinc (DB01593): A Comprehensive Monograph on its Physicochemical Properties, Physiological Significance, and Clinical Pharmacology

Introduction: Zinc as an Essential Element and Therapeutic Agent

Executive Summary

Zinc, a metallic element identified by the symbol Zn, occupies a unique and indispensable position in biology and medicine.[1] It is recognized both as an essential trace element, fundamental to a vast array of physiological processes, and as a small molecule therapeutic agent (DrugBank ID: DB01593) used for the treatment and prevention of specific clinical conditions.[1] As the second most abundant trace metal in the human body after iron, zinc is integral to the structure and function of every cell, participating in catalytic, structural, and regulatory roles that underpin life itself.[2] Its involvement spans from gene expression and protein synthesis to immune defense and metabolic regulation.[4]

The central theme governing the biological and pharmacological effects of zinc is homeostasis. The human body employs a sophisticated network of transporters and binding proteins to maintain zinc concentrations within a narrow physiological range.[7] This delicate balance is critical, as deviations in either direction lead to distinct and significant pathologies. Zinc deficiency, a condition estimated to affect up to a third of the world's population, is associated with a spectrum of adverse outcomes, including growth retardation, impaired immune function, chronic diarrhea, and delayed wound healing.[1] Conversely, excessive zinc intake can lead to acute gastrointestinal distress and, more insidiously, chronic toxicity manifesting as copper deficiency with subsequent hematological and neurological complications.[9]

Continue reading the full research report

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/02/26
Not Applicable
Recruiting
2024/11/04
Not Applicable
ENROLLING_BY_INVITATION
Kasr El Aini Hospital
2024/10/29
Phase 4
Not yet recruiting
2024/08/23
Phase 2
Not yet recruiting
2024/08/06
Not Applicable
Completed
2024/05/28
Phase 3
Not yet recruiting
2024/03/12
Phase 4
Completed
Second Affiliated Hospital of Xi'an Jiaotong University
2024/03/04
Phase 3
Not yet recruiting
2024/02/15
Phase 2
Not yet recruiting
2023/11/30
Phase 4
Recruiting

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Newton Laboratories, Inc.
55714-2596
ORAL
15 [hp_X] in 1 mL
5/21/2025
Avion Pharmaceuticals, LLC
75854-344
ORAL
15 mg in 1 1
4/8/2025
Avion Pharmaceuticals, LLC
75854-320
ORAL
12 mg in 1 1
1/18/2021
Newton Laboratories, Inc.
55714-4862
ORAL
15 [hp_X] in 1 mL
5/21/2025
The Wellness Center
50181-0030
ORAL
1 [hp_M] in 1 mL
5/28/2025
Deseret Biologicals, Inc.
43742-2218
ORAL
30 [hp_X] in 1 mL
5/27/2025
King Bio Inc.
57955-2822
ORAL
10 [hp_X] in 59 mL
5/20/2025
Dr. Masood Homeopathic Pharmaceuticals Private Limited
82797-132
ORAL
0.01 mg in 120 mL
4/24/2025
METHOD PHARMACEUTICALS, LLC
58657-170
ORAL
25 mg in 1 1
12/10/2023
Everett Laboratories, Inc.
0642-0092
ORAL
15 mg in 1 1
4/18/2012

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
Authorised
10/12/2004

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
BRAUER CALM Oral Spray
65600
Medicine
A
7/31/1998
Restless Legs Relief
169216
Medicine
A
2/18/2010
Hair Assist Women's Foam
400972
Medicine
A
12/12/2022
Calm Oral Liquid
492207
Medicine
A
6/19/2025
Calm Oral Liquid
455427
Medicine
A
7/16/2024
HAIR ASSIST
115642
Medicine
A
1/14/2005
Calm Oral Liquid
345751
Medicine
A
10/12/2020
Hair Assist Men's Foam
400970
Medicine
A
12/12/2022
BRAUER CALM TABLETS
65601
Medicine
A
7/31/1998
DANMOT HERBALIX CHELATION FORMULA tablet bulk
52268
Danmot Pty Ltd
Medicine
A
4/18/1995

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
CELL-WISE
melaleuca of canada inc.
02236914
Tablet - Oral
7.5 MG / TAB
1/12/1998
ZINCUM METALLICUM GRANULE (3X-30X)
laboratoires holis inc.
01954938
Tablet - Oral
3 X / TAB
12/31/1984
VARICO HP
terra botanica products ltd.
02233385
Liquid - Oral
30 X
5/25/1998
ZINCUM METALLICUM GOUTTE 4CH-30CH
dolisos laboratoires s.a.
00668184
Drops - Oral
4 CH / CH
12/31/1987
ZINCUM MET GOUTTE 4CH-30CH
boiron laboratoires
00675601
Drops - Oral
4 CH / CH
12/31/1987
THC COMPLEX #71
total health centre
02236390
Drops - Oral
3 X
3/29/1998
DIATHESIS V-I
bio active canada ltd.
02234231
Liquid - Oral
8 X
5/26/1998
BOROPLEX
bio active canada ltd.
02233591
Liquid - Oral
3 X
5/26/1998
ZINCUM METALLICUM
dolisos canada inc.
02234802
Granules ,  Globules ,  Liquid - Oral
3 X
1/5/1998
NOVA 7034 - LIQ
nova homeopathic therapeutics inc.
02121603
Liquid - Oral
8 X / ML
2/21/1995

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
ELEVIT COMPRIMIDOS RECUBIERTOS CON PELICULA
Bayer Hispania S.L.
67267
COMPRIMIDO RECUBIERTO CON PELÍCULA
Sin Receta
Not Commercialized

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.